Phase I Clinical Trial in Humans using Human Fetal Derived Glial Restricted Progenitor Cells ("Q Cells") In Transverse Myelitis

Grant

Date/time Interval

  • November 1, 2019 - November 2, 2019
  • Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • Inmaculada Aban   Principal Investigator